About This Research Study
Type 1 diabetes is an autoimmune condition where the body attacks insulin-producing cells in the pancreas, leading to a lifelong dependence on insulin therapy. Tekton Research is now enrolling participants for a clinical trial evaluating an investigational medication for people living with type 1 diabetes. People with T1D who are currently receiving one or more daily insulin injections may be eligible to participate.
Eligible participants…
- Must be age 18-35 and recently diagnosed with T1D
- Must be receiving one or more daily insulin injections, not longer than 90 days prior screening
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.